Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Posted on:
Date limite d´inscription:
Expired
Type
Research/project funding
Reference Number
RFA-RM-22-014
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications on the optimization and characterization of technologies and assays with the potential for utilization and adoption in regulatory submissions of genome editing therapeutics.
Categories: Health.
Categories: Health.
États-Unis